Biblio Discovery — Demo Discovery Service

172 results for "Heuser, Michael"

Showing 1–20 · 2.00 seconds · RSS

  1. Journal Article Full text

    Therapy-related myeloid neoplasms: does knowing the origin help to guide treatment?

    Heuser, Michael

    Hematology Am Soc Hematol Educ Program · 2016 · English · PubMed Central

    Therapy-related myeloid neoplasms (t-MN) combine t-MDS and therapy related acute myeloid leukemia (t-AML) patients in one entity because of their similar pathogenesis, rapid progression from t-MDS to t-AML, and their equally poor prognosis. Treatment with epipodophyllotoxins like etoposide has been…

  2. Journal Article Full text

    Exploiting differential RNA splicing patterns: A potential new group of therapeutic targets in cancer

    Jyotsana, Nidhi; Heuser, Michael

    Expert Opin Ther Targets · 2017 · English · PubMed Central

    INTRODUCTION: Genetic characterization of cancer has uncovered the importance of differential or alternative RNA splicing for cancer development. Mutations in genes associated with splicing have been found in hematologic malignancies, but also in some solid cancers. Aberrant cancer specific RNA…

  3. Journal Article Full text

    Mouse Models of Frequently Mutated Genes in Acute Myeloid Leukemia

    Mohanty, Sagarajit; Heuser, Michael

    Cancers (Basel) · 2021 · English · PubMed Central

    SIMPLE SUMMARY: Acute myeloid leukemia is a genetically heterogeneous disease and shows variable treatment outcomes. Genetic profiling has revealed different driver mutations in AML patients. Therefore, it is important to understand the biological impact of these mutations in leukemia…

  4. Journal Article Full text

    Resistance to targeted therapies in acute myeloid leukemia

    Mecklenbrauck, Rabea; Heuser, Michael

    Clin Exp Metastasis · 2022 · English · PubMed Central

    The introduction of new targeted therapies to the treatment algorithm of acute myeloid leukemia (AML) offers new opportunities, but also presents new challenges. Patients diagnosed with AML receiving targeted therapies as part of lower intensity regimens will relapse inevitably due to primary or…

  5. Journal Article Full text

    Mutation- and MRD-informed treatment decisions for the transplant-eligible AML patient

    Heuser, Michael; Shahswar, Rabia

    Hematology Am Soc Hematol Educ Program · 2024 · English · PubMed Central

    Acute myeloid leukemia (AML) is classified by risk groups according to a number of genetic mutations, which may occur alone or in combination with other mutations and chromosomal abnormalities. Prognosis and appropriate therapy can vary significantly based on a patient's genetic risk group, making…

  6. Journal Article Full text

    Treatment for Relapsed/Refractory Acute Myeloid Leukemia

    Thol, Felicitas; Heuser, Michael

    Hemasphere · 2021 · English · PubMed Central

    Patients with relapsed or refractory (r/r) acute myeloid leukemia (AML) have a poor prognosis and treatment remains challenging. For the majority of r/r patients, allogeneic hematopoietic stem cell transplantation (HSCT) is the only curative treatment approach. Salvage therapy is given in order to…

  7. Journal Article Full text

    Clonal Hematopoiesis of Indeterminate Potential

    Heuser, Michael; Thol, Felicitas; Ganser, Arnold

    Dtsch Arztebl Int · 2016 · English · PubMed Central

    BACKGROUND: Patients with cytopenia are increasingly undergoing molecular genetic tests of periperal blood or bone marrow for diagnostic purposes. These tests can detect genetic mutations that do not have any morphological correlate in hematologic neoplasia such as myelodysplastic syndrome (MDS). A…

  8. Journal Article Full text

    Epigenetics in myelodysplastic syndromes

    Heuser, Michael; Yun, Haiyang; Thol, Felicitas

    Semin Cancer Biol · 2017 · English · PubMed Central

    Epigenetic regulators are the largest group of genes mutated in MDS patients. Most mutated genes belong to one of three groups of genes with normal functions in DNA methylation, in H3K27 methylation/acetylation or in H3K4 methylation. Mutations in the majority of epigenetic regulators disrupt their…

  9. Journal Article Full text

    Understanding differential technologies for detection of MRD and how to incorporate into clinical practice

    Cloos, Jacqueline; Ngai, Lok Lam; Heuser, Michael

    Hematology Am Soc Hematol Educ Program · 2023 · English · PubMed Central

    Patient- and leukemia-specific factors assessed at diagnosis classify patients with acute myeloid leukemia (AML) in risk categories that are prognostic for outcome. The induction phase with intensive chemotherapy in fit patients aims to reach a complete remission (CR) of less than 5% blasts in bone…

  10. Journal Article Full text

    Monocytes reprogrammed with lentiviral vectors co-expressing GM-CSF, IFN-α2 and antigens for personalized immune therapy of acute leukemia pre- or post-stem cell transplantation

    Bialek-Waldmann, Julia K.; Heuser, Michael; Ganser, Arnold et al.

    Cancer Immunol Immunother · 2019 · English · PubMed Central

    Acute myeloid leukemia (AML) is the most common acute leukemia in adults and overall survival remains poor. Chemotherapy is the standard of care for intensive induction therapy. Patients who achieve a complete remission require post-remission therapies to prevent relapse. There is no standard of…

  11. Journal Article Full text

    Relapse Prevention in Acute Myeloid Leukemia: The Role of Immunotherapy with Histamine Dihydrochloride and Low-Dose Interleukin-2

    Montesinos, Pau; Buccisano, Francesco; Cluzeau, Thomas et al.

    Cancers (Basel) · 2024 · English · PubMed Central

    SIMPLE SUMMARY: The treatment of acute myeloid leukemia (AML) has improved in recent decennia by targeted therapy and allogeneic stem cell transplantation (allo-SCT). Hematological relapse in patients who have attained complete remission (CR) after chemotherapy remains a significant cause of…

  12. Journal Article Full text

    Therapierefraktäre Anämie bei einem 35-jährigen Dialysepatienten nach Herztransplantation

    Schröder, Christoph; Roeles, Johannes; Schwarzer, Adrian et al.

    Internist (Berl) · 2021 · German · PubMed Central

    This article presents a case of pure red cell aplasia in a 35-year-old heart transplant recipient on chronic hemodialysis. Elevated parvovirus B19 immunoglobulin M blood levels were detected along with a high viral load of 80 billion IU/ml quantified by polymerase chain reaction. Bone marrow…

  13. Journal Article Full text

    DNMT3A mutations are rare in childhood acute myeloid leukemia

    Thol, Felicitas; Heuser, Michael; Damm, Frederik et al.

    Haematologica · 2011 · English · PubMed Central

  14. Journal Article Full text

    Teleradiotherapy Network: Applications and Feasibility for Providing Cost-Effective Comprehensive Radiotherapy Care in Low- and Middle-Income Group Countries for Cancer Patients

    Datta, Niloy Ranjan; Heuser, Michael; Samiei, Massoud et al.

    Telemed J E Health · 2015 · English · PubMed Central

    Globally, new cancer cases will rise by 57% within the next two decades, with the majority in the low- and middle-income countries (LMICs). Consequently, a steep increase of about 40% in cancer deaths is expected there, mainly because of lack of treatment facilities, especially radiotherapy…

  15. Journal Article Full text

    Evaluation of the Relationship of Glasdegib Exposure and Safety End Points in Patients With Refractory Solid Tumors and Hematologic Malignancies

    Ruiz‐Garcia, Ana; Shaik, Naveed; Lin, Swan et al.

    J Clin Pharmacol · 2020 · English · PubMed Central

    Glasdegib is approved for treating acute myeloid leukemia in elderly patients at 100 mg once daily in combination with low‐dose cytarabine. Exposure‐efficacy analysis showed that the survival benefit of glasdegib was not glasdegib exposure‐dependent. The relationship between glasdegib exposure and…

  16. Journal Article Full text

    VH1 Family Immunoglobulin Repertoire Sequencing after Allogeneic Hematopoietic Stem Cell Transplantation

    Sethi, Maya K.; Thol, Felicitas; Stadler, Michael et al.

    PLoS One · 2017 · English · PubMed Central

    After allogeneic hematopoietic stem cell transplantation (HSCT), recovery of humoral immunity is essential to protect from life-threatening infections. However, monitoring the humoral immune system after transplantation with standard techniques in the clinical routine is imprecise. Here, we…

  17. Journal Article Full text

    Elevated frequencies of leukemic myeloid and plasmacytoid dendritic cells in acute myeloid leukemia with the FLT3 internal tandem duplication

    Rickmann, Mareike; Krauter, Juergen; Stamer, Kathrin et al.

    Ann Hematol · 2011 · English · PubMed Central

    Some 30% of acute myeloid leukemia (AML) patients display an internal tandem duplication (ITD) mutation in the FMS-like tyrosine kinase 3 (FLT3) gene. FLT3-ITDs are known to drive hematopoietic stem cells towards FLT3 ligand independent growth, but the effects on dendritic cell (DC) differentiation…

  18. Journal Article Full text

    Meningioma 1 is indispensable for mixed lineage leukemia-rearranged acute myeloid leukemia

    Sharma, Amit; Jyotsana, Nidhi; Gabdoulline, Razif et al.

    Haematologica · 2019 · English · PubMed Central

    Mixed lineage leukemia (MLL/KMT2A) rearrangements (MLL-r) are one of the most frequent chromosomal aberrations in acute myeloid leukemia. We evaluated the function of Meningioma 1 (MN1), a co-factor of HOXA9 and MEIS1, in human and murine MLL-rearranged leukemia by CRISPR-Cas9 mediated deletion of…

  19. Journal Article Full text

    Newly diagnosed isolated myeloid sarcoma–paired NGS panel analysis of extramedullary tumor and bone marrow

    Engel, Nils W.; Reinert, Jochim; Borchert, Nora M. et al.

    Ann Hematol · 2020 · English · PubMed Central

    Isolated myeloid sarcoma (MS) is a rare malignancy in which myeloid blast forms tumors at various locations while the bone marrow (BM) remains cytomorphologically free from disease. We analyzed isolated MS from four patients and their BMs at initial diagnosis and follow-up, using a custom…